2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Revenue | $648M | $726M | $576M | $511M | $488M |
Cost of Revenue | $343M | $431M | $365M | $339M | $307M |
Gross Profit | $305M | $295M | $211M | $172M | $181M |
Gross Profit % | 47% | 41% | 37% | 34% | 37% |
R&D Expenses | $6M | $6.9M | $8.8M | $12M | $13M |
2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Net Income | $11M | $3.9M | -$90M | -$121M | -$98M |
Dep. & Amort. | $7.9M | $9.5M | $17M | $25M | $35M |
Def. Tax | -$12M | -$7.6M | $52M | $0 | $0 |
Stock Comp. | $2.2M | $3.4M | $3.4M | $4.9M | $2.8M |
Chg. in WC | $7.1M | -$21M | -$7.2M | $22M | $4.3M |
2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Cash | $123M | $92M | $42M | $27M | $29M |
ST Investments | $0 | $0 | $0 | $0 | $0 |
Cash & ST Inv. | $123M | $92M | $42M | $27M | $29M |
Receivables | $29M | $25M | $35M | $38M | $33M |
Inventory | $66M | $99M | $73M | $67M | $57M |
Purple Innovation achieved adjusted EBITDA profitability for the first time in August 2024 and generated positive cash flow in Q4, driven by operational improvements and cost-saving initiatives.
Gross margin for Q4 2024 reached 42.9%, up 970 basis points year-over-year, with adjusted gross margin at 44.9%. The company expects gross margin to expand by at least 200 basis points in 2025.
The company launched its new Rejuvenate 2.0 luxury mattress line, with a full wholesale rollout expected by Q3 2025, and anticipates significant contributions to revenue growth and profitability from this product.
For 2025, Purple expects total revenue of $465M to $485M and adjusted EBITDA ranging from flat to $10M, with sequential revenue growth and positive EBITDA anticipated in the second half of the year.
The company is undergoing a strategic review of alternatives, including potential partnerships or transactions, while maintaining a focus on innovation, differentiation, and gross margin improvements.